{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:10:01Z","timestamp":1790201401009,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.clinthera.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:28:21Z","timestamp":1467160101000},"page":"1653-1664.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes"],"prefix":"10.1016","volume":"38","author":[{"given":"C. Victor","family":"Spain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Wivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.05.009_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjmed.2008.11.013","article-title":"Adherence to healthy lifestyle habits in US adults, 1988-2006","volume":"122","author":"King","year":"2009","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2016.05.009_bib2","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib3","series-title":"Adherence to long-term therapies: evidence for action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.clinthera.2016.05.009_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.clinthera.2016.05.009_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clinthera.2011.01.019","article-title":"A review of diabetes treatment adherence and the association with clinical and economic outcomes","volume":"33","author":"Asche","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2016.05.009_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2016.05.009_bib7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1377\/hlthaff.2011.1198","article-title":"Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually","volume":"31","author":"Jha","year":"2012","journal-title":"Health Aff"},{"key":"10.1016\/j.clinthera.2016.05.009_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/dc08-1311","article-title":"Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings","volume":"32","author":"Stuart","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/dme.12046","article-title":"Longitudinal association between medication adherence and glycaemic control in type 2 diabetes","volume":"30","author":"Aikens","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2016.05.009_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1185\/03007990903421994","article-title":"Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization","volume":"26","author":"Cooke","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.05.009_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1464-5491.2012.03605.x","article-title":"Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study","volume":"29","author":"Peyrot","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2016.05.009_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1185\/03007995.2013.821056","article-title":"Predictors of medication adherence in patients with type 2 diabetes mellitus","volume":"29","author":"Curkendall","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.05.009_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clinthera.2013.03.021","article-title":"Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 \u03bcg","volume":"35","author":"Malmen\u00e4s","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2016.05.009_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13300-014-0065-z","article-title":"Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus","volume":"5","author":"Ascher-Svanum","year":"2014","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.clinthera.2016.05.009_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40271-014-0068-x","article-title":"Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities","volume":"7","author":"Brod","year":"2014","journal-title":"Patient"},{"key":"10.1016\/j.clinthera.2016.05.009_bib16","series-title":"National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014","year":"2014"},{"key":"10.1016\/j.clinthera.2016.05.009_bib17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/0145721709345773","article-title":"Barriers to insulin injection therapy: patient and health care provider perspectives","volume":"35","author":"Rubin","year":"2009","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.clinthera.2016.05.009_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/diacare.23.6.739","article-title":"The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy","volume":"23","author":"Anderson","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc09-1348","article-title":"Correlates of insulin injection omission","volume":"33","author":"Peyrot","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40271-013-0029-9","article-title":"Insulin administration and the impacts of forgetting a dose","volume":"7","author":"Brod","year":"2013","journal-title":"Patient"},{"key":"10.1016\/j.clinthera.2016.05.009_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaclin.31.4.148","article-title":"Practical use of glucagon-like peptide-1 receptor agonist therapy in primary care","volume":"31","author":"Reid","year":"2013","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.clinthera.2016.05.009_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1369-7625.2010.00619.x","article-title":"Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008","volume":"14","author":"McHorney","year":"2010","journal-title":"Health Expect"},{"key":"10.1016\/j.clinthera.2016.05.009_bib33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/PPA.S58781","article-title":"Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes","volume":"8","author":"Walz","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.clinthera.2016.05.009_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/PPA.S58813","article-title":"Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence","volume":"8","author":"Lopez","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.clinthera.2016.05.009_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diabres.2012.01.002","article-title":"Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus","volume":"96","author":"Green","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2016.05.009_bib36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1463-1326.2009.01123.x","article-title":"Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain","volume":"11","author":"Marrett","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2016.05.009_bib37","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1185\/03007990903073654","article-title":"Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study","volume":"25","author":"Peyrot","year":"2009","journal-title":"Current Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.05.009_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2337\/dc08-1533","article-title":"Diabetic patients\u05f3 medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments","volume":"32","author":"Aikens","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib39","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2105\/AJPH.94.10.1782","article-title":"Cost-related medication underuse among chronically iII adults: the treatments people forgo, how often, and who is at risk","volume":"94","author":"Piette","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clinthera.2016.05.009_bib40","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","article-title":"Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib41","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/dc11-2342","article-title":"Psychometric evaluation of the adherence in diabetes questionnaire","volume":"35","author":"Kristensen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.05.009_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diaclin.22.3.147","article-title":"What\u05f3s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes","volume":"22","author":"Polonsky","year":"2004","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.clinthera.2016.05.009_bib43","first-page":"786","article-title":"Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence","volume":"20","author":"van Boven","year":"2014","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816303757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816303757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T17:57:09Z","timestamp":1536602229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816303757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0149291816303757"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.05.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}